|
|
||||||||
Alzheimer Disease Research Center (Drs. Lopez, Becker, Rosen, and Bajulaiye), and the Departments of Psychiatry (Drs. Becker, Brenner, Rosen, Bajulaiye, and Reynolds) and Neurology (Drs. Lopez, Becker, and Brenner), University of Pittsburgh School of Medicine, Pittsburgh, PA.
We longitudinally evaluated the neuropsychological functions, rate of progression, and waking EEG findings in 17 patients with probable Alzheimer's disease (AD) with delusions and hallucinations, and compared them with those of matched AD patients without delusions and hallucinations. AD patients with delusions and hallucinations had a more rapid rate of decline, as measured by the Mini-Mental State Examination, a specific defect in receptive language, and a greater frequency of aggression and hostility. Visual EEG analysis showed that these patients had a significantly greater proportion of moderately abnormal EEGs, and spectral analysis confirmed the increased amount of delta and theta activity. These data demonstrate that AD patients with delusions and hallucinations have a greater degree of cerebral dysfunction and a relatively focal neuropsychological defect, which may indicate a localized pathologic abnormality.
Address correspondence and reprint requests to Dr. Oscar L. Lopez, Alzheimer's Disease Research Center, Suite 400, Iroquois Building, 3600 Forbes Ave, Pittsburgh, PA 15213.
Supported by funds from the National Institute on Aging (AG-5133), the Alzheimer's Disease and Related Disorders Association (IIRG-88-061; to J.T.B.) the National Institute of Mental Health (MH 30915), and the RSDA-II to C.F.R. (MH000295). O.I.B. was a Behavioral Neurology of Aging fellow at the University of Pittsburgh (AG-00128).
Presented in part at the 19th annual meeting of the International Neuropsychological Society, San Antonio, TX, 1991.
Received August 9, 1990. Accepted for publication in final form November 30, 1990.
This article has been cited by other articles:
![]() |
P. Aalten, J. Jolles, M. E. de Vugt, and F. R.J. Verhey The Influence of Neuropsychological Functioning on Neuropsychiatric Problems in Dementia J Neuropsychiatry Clin Neurosci, February 1, 2007; 19(1): 50 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stavitsky, A. M. Brickman, N. Scarmeas, R. L. Torgan, M.-X. Tang, M. Albert, J. Brandt, D. Blacker, and Y. Stern The progression of cognition, psychiatric symptoms, and functional abilities in dementia with lewy bodies and Alzheimer disease. Arch Neurol, October 1, 2006; 63(10): 1450 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Leonard, M. E. Tinetti, H. G. Allore, and M. A. Drickamer Potentially modifiable resident characteristics that are associated with physical or verbal aggression among nursing home residents with dementia. Arch Intern Med, June 26, 2006; 166(12): 1295 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kazui, N. Hirono, M. Hashimoto, Y. Nakano, K. Matsumoto, Y. Takatsuki, E. Mori, Y. Ikejiri, and M. Takeda Symptoms Underlying Unawareness of Memory Impairment in Patients With Mild Alzheimer's Disease J Geriatr Psychiatry Neurol, March 1, 2006; 19(1): 3 - 12. [Abstract] [PDF] |
||||
![]() |
S. A. Ropacki and D. V. Jeste Epidemiology of and Risk Factors for Psychosis of Alzheimer's Disease: A Review of 55 Studies Published From 1990 to 2003 Am J Psychiatry, November 1, 2005; 162(11): 2022 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Schneider, K. S. Dagerman, and P. Insel Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia: Meta-analysis of Randomized Placebo-Controlled Trials JAMA, October 19, 2005; 294(15): 1934 - 1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Scarmeas, J. Brandt, M. Albert, G. Hadjigeorgiou, A. Papadimitriou, B. Dubois, M. Sarazin, D. Devanand, L. Honig, K. Marder, et al. Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease Arch Neurol, October 1, 2005; 62(10): 1601 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Kang, S. H. Choi, B. H. Lee, Y. Jeong, D. S. Hahm, I. W. Han, J. L. Cummings, and D. L. Na Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI) J Geriatr Psychiatry Neurol, March 1, 2004; 17(1): 32 - 35. [Abstract] [PDF] |
||||
![]() |
M. M. Bassiony and C. G. Lyketsos Delusions and Hallucinations in Alzheimer's Disease: Review of the Brain Decade Psychosomatics, October 1, 2003; 44(5): 388 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Lopez, J. T. Becker, R. A. Sweet, W. Klunk, D. I. Kaufer, J. Saxton, M. Habeych, and S. T. DeKosky Psychiatric Symptoms Vary With the Severity of Dementia in Probable Alzheimer's Disease J Neuropsychiatry Clin Neurosci, August 1, 2003; 15(3): 346 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Sweet, R. L. Hamilton, M. T. Healy, S. R. Wisniewski, R. Henteleff, B. G. Pollock, D. A. Lewis, and S. T. DeKosky Alterations of Striatal Dopamine Receptor Binding in Alzheimer Disease Are Associated With Lewy Body Pathology and Antemortem Psychosis Arch Neurol, March 1, 2001; 58(3): 466 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Lopez, G. Smith, J. T. Becker, C. C. Meltzer, and S. T. DeKosky The Psychotic Phenomenon in Probable Alzheimer's Disease : A Positron Emission Tomography Study J Neuropsychiatry Clin Neurosci, February 1, 2001; 13(1): 50 - 55. [Abstract] [Full Text] |
||||
![]() |
R. S Wilson, D. W Gilley, D. A Bennett, L. A Beckett, and D. A Evans Hallucinations, delusions, and cognitive decline in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 172 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Paulsen, D. P. Salmon, L. J. Thal, R. Romero, C. Weisstein-Jenkins, D. Galasko, C. R. Hofstetter, R. Thomas, I. Grant, and D. V. Jeste Incidence of and risk factors for hallucinations and delusions in patients with probable AD Neurology, May 23, 2000; 54(10): 1965 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Lopez, S. Wisniewski, R. L. Hamilton, J. T. Becker, D. I. Kaufer, and S. T. DeKosky Predictors of progression in patients with AD and Lewy bodies Neurology, May 9, 2000; 54(9): 1774 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Lopez, S. R. Wisniewski, J. T. Becker, F. Boller, and S. T. DeKosky Psychiatric Medication and Abnormal Behavior as Predictors of Progression in Probable Alzheimer Disease Arch Neurol, October 1, 1999; 56(10): 1266 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rao and C. G. Lyketsos Delusions in Alzheimer's Disease: A Review J Neuropsychiatry Clin Neurosci, November 1, 1998; 10(4): 373 - 382. [Abstract] [Full Text] |
||||
![]() |
N. Hirono, E. Mori, M. Yasuda, Y. Ikejiri, T. Imamura, T. Shimomura, M. Ikeda, M. Hashimoto, and H. Yamashita Factors associated with psychotic symptoms in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, May 1, 1998; 64(5): 648 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Victoroff, C. Zarow, W. J. Mack, E. Hsu, and H. C. Chui Physical Aggression Is Associated With Preservation of Substantia Nigra Pars Compacta in Alzheimer Disease Arch Neurol, May 1, 1996; 53(5): 428 - 434. [Abstract] [PDF] |
||||
![]() |
H. C. Chui, S. A. Lyness, E. Sobel, and L. S. Schneider Extrapyramidal Signs and Psychiatric Symptoms Predict Faster Cognitive Decline in Alzheimer's Disease Arch Neurol, July 1, 1994; 51(7): 676 - 681. [Abstract] [PDF] |
||||
![]() |
J. T. Becker, F. Boiler, O. L. Lopez, J. Saxton, K. L. McGonigle, and Alzheimer Research Program The Natural History of Alzheimer's Disease: Description of Study Cohort and Accuracy of Diagnosis Arch Neurol, June 1, 1994; 51(6): 585 - 594. [Abstract] [PDF] |
||||
![]() |
O. L. Lopez, J. T. Becker, D. Rezek, J. Wess, F. Boiler, C. F. Reynolds III, and M. Panisset Neuropsychiatric Correlates of Cerebral White-Matter Radiolucencies in Probable Alzheimer's Disease Arch Neurol, August 1, 1992; 49(8): 828 - 834. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |